{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T02:49:02Z","timestamp":1780368542236,"version":"3.54.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T00:00:00Z","timestamp":1724112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T00:00:00Z","timestamp":1724112000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20K09570"],"award-info":[{"award-number":["20K09570"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23K08728"],"award-info":[{"award-number":["23K08728"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Human Cell"],"DOI":"10.1007\/s13577-024-01118-2","type":"journal-article","created":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T08:02:25Z","timestamp":1724140945000},"page":"1706-1718","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Exploring the relationship between ulcerative colitis, colorectal cancer, and prostate cancer"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-8785-3177","authenticated-orcid":false,"given":"Yurie","family":"Kura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4011-6572","authenticated-orcid":false,"given":"Marco A.","family":"De Velasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1822-2720","authenticated-orcid":false,"given":"Kazuko","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3665-9523","authenticated-orcid":false,"given":"Hirotsugu","family":"Uemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6774-7497","authenticated-orcid":false,"given":"Kazutoshi","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8275-0846","authenticated-orcid":false,"given":"Kazuto","family":"Nishio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,20]]},"reference":[{"issue":"12","key":"1118_CR1","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1038\/s41591-019-0675-0","volume":"25","author":"D Furman","year":"2019","unstructured":"Furman D, Campisi J, Verdin E, Carrera-Bastos P, Targ S, Franceschi C, et al. Chronic inflammation in the etiology of disease across the life span. Nat Med. 2019;25(12):1822\u201332.","journal-title":"Nat Med"},{"issue":"2","key":"1118_CR2","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1093\/carcin\/bgn267","volume":"30","author":"DW Rosenberg","year":"2009","unstructured":"Rosenberg DW, Giardina C, Tanaka T. Mouse models for the study of colon carcinogenesis. Carcinogenesis. 2009;30(2):183\u201396.","journal-title":"Carcinogenesis"},{"issue":"12","key":"1118_CR3","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.3109\/00365521.2013.846402","volume":"48","author":"A Jussila","year":"2013","unstructured":"Jussila A, Virta LJ, Pukkala E, F\u00e4rkkil\u00e4 MA. Malignancies in patients with inflammatory bowel disease: a nationwide register study in Finland. Scand J Gastroenterol. 2013;48(12):1405\u201313.","journal-title":"Scand J Gastroenterol"},{"issue":"2","key":"1118_CR4","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.cgh.2013.03.034","volume":"12","author":"MD Kappelman","year":"2014","unstructured":"Kappelman MD, Farkas DK, Long MD, Erichsen R, Sandler RS, S\u00f8rensen HT, et al. Risk of cancer in patients with inflammatory bowel diseases: a nationwide population-based cohort study with 30 years of follow-up evaluation. Clin Gastroenterol Hepatol. 2014;12(2):265-73.e1.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"1118_CR5","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1093\/ibd\/izx046","volume":"24","author":"CA Mosher","year":"2018","unstructured":"Mosher CA, Brown GR, Weideman RA, Crook TW, Cipher DJ, Spechler SJ, et al. Incidence of colorectal cancer and extracolonic cancers in veteran patients with inflammatory bowel disease. Inflamm Bowel Dis. 2018;24(3):617\u201323.","journal-title":"Inflamm Bowel Dis"},{"issue":"5","key":"1118_CR6","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.eururo.2018.11.039","volume":"75","author":"JA Burns","year":"2019","unstructured":"Burns JA, Weiner AB, Catalona WJ, Li EV, Schaeffer EM, Hanauer SB, et al. Inflammatory bowel disease and the risk of prostate cancer. Eur Urol. 2019;75(5):846\u201352.","journal-title":"Eur Urol"},{"issue":"6","key":"1118_CR7","doi-asserted-by":"publisher","first-page":"285","DOI":"10.3390\/medicina56060285","volume":"56","author":"E Carli","year":"2020","unstructured":"Carli E, Caviglia GP, Pellicano R, Fagoonee S, Rizza S, Astegiano MS, et al. Incidence of prostate cancer in inflammatory bowel disease: a meta-analysis. Medicina (Kaunas). 2020;56(6):285.","journal-title":"Medicina (Kaunas)"},{"issue":"1","key":"1118_CR8","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41391-019-0177-7","volume":"23","author":"Y Ge","year":"2020","unstructured":"Ge Y, Shi Q, Yao W, Cheng Y, Ma G. The association between inflammatory bowel disease and prostate cancer risk: a meta-analysis. Prostate Cancer Prostatic Dis. 2020;23(1):53\u20138.","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"10","key":"1118_CR9","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1002\/ijc.33048","volume":"147","author":"TJ Meyers","year":"2020","unstructured":"Meyers TJ, Weiner AB, Graff RE, Desai AS, Cooley LF, Catalona WJ, et al. Association between inflammatory bowel disease and prostate cancer: a large-scale, prospective, population-based study. Int J Cancer. 2020;147(10):2735\u201342.","journal-title":"Int J Cancer"},{"issue":"2","key":"1118_CR10","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1001\/jamaoncol.2021.5680","volume":"8","author":"MM He","year":"2022","unstructured":"He MM, Lo CH, Wang K, Polychronidis G, Wang L, Zhong R, et al. Immune-mediated diseases associated with cancer risks. JAMA Oncol. 2022;8(2):209\u201319.","journal-title":"JAMA Oncol"},{"key":"1118_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.prnil.2024.05.001","author":"G Jung","year":"2024","unstructured":"Jung G, Song B, Kim JK, Kim H, Lee J, Hong SK. The association between inflammatory bowel disease and risk of prostate cancer: a population-based retrospective study based on Korean National Health Insurance Service database. Prostate Int. 2024. https:\/\/doi.org\/10.1016\/j.prnil.2024.05.001.","journal-title":"Prostate Int"},{"issue":"11","key":"1118_CR12","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1007\/s00535-016-1199-8","volume":"51","author":"JC Wilson","year":"2016","unstructured":"Wilson JC, Furlano RI, Jick SS, Meier CR. A population-based study examining the risk of malignancy in patients diagnosed with inflammatory bowel disease. J Gastroenterol. 2016;51(11):1050\u201362.","journal-title":"J Gastroenterol"},{"issue":"15","key":"1118_CR13","doi-asserted-by":"publisher","first-page":"175628482211374","DOI":"10.1177\/17562848221137430","volume":"21","author":"JE Na","year":"2022","unstructured":"Na JE, Kim TJ, Lee YC, Kim JE, Kim ER, Hong SN, et al. Risk of prostate cancer in patients with inflammatory bowel disease: a nationwide cohort study in South Korea. Therap Adv Gastroenterol. 2022;21(15):17562848221137430.","journal-title":"Therap Adv Gastroenterol"},{"issue":"9","key":"1118_CR14","first-page":"5611","volume":"9","author":"SH Ko","year":"2016","unstructured":"Ko SH, Baeg MK, Bae WJ, Kim P, Choi MG. Prostate cancer patients may have an increased risk of coexisting advanced colorectal neoplasms. Onco Targets Ther. 2016;9(9):5611\u20137.","journal-title":"Onco Targets Ther"},{"issue":"8","key":"1118_CR15","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1002\/cncr.29919","volume":"122","author":"D Desautels","year":"2016","unstructured":"Desautels D, Czaykowski P, Nugent Z, Demers AA, Mahmud SM, Singh H. Risk of colorectal cancer after the diagnosis of prostate cancer: a population-based study. Cancer. 2016;122(8):1254\u201360.","journal-title":"Cancer"},{"issue":"1","key":"1118_CR16","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1186\/s12885-017-3873-5","volume":"17","author":"JL Beebe-Dimmer","year":"2017","unstructured":"Beebe-Dimmer JL, Yee C, Paskett E, Schwartz AG, Lane D, Palmer NRA, et al. Family history of prostate and colorectal cancer and risk of colorectal cancer in the Women\u2019s health initiative. BMC Cancer. 2017;17(1):848.","journal-title":"BMC Cancer"},{"issue":"1","key":"1118_CR17","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","volume":"51","author":"FR Greten","year":"2019","unstructured":"Greten FR, Grivennikov SI. Inflammation and cancer: triggers, mechanisms, and consequences. Immunity. 2019;51(1):27\u201341.","journal-title":"Immunity"},{"issue":"9","key":"1118_CR18","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1093\/carcin\/bgu143","volume":"35","author":"MA De Velasco","year":"2014","unstructured":"De Velasco MA, Tanaka M, Yamamoto Y, Hatanaka Y, Koike H, Nishio K, et al. Androgen deprivation induces phenotypic plasticity and promotes resistance to molecular targeted therapy in a PTEN-deficient mouse model of prostate cancer. Carcinogenesis. 2014;35(9):2142\u201353.","journal-title":"Carcinogenesis"},{"issue":"13","key":"1118_CR19","doi-asserted-by":"publisher","first-page":"15959","DOI":"10.18632\/oncotarget.7557","volume":"7","author":"MA De Velasco","year":"2016","unstructured":"De Velasco MA, Kura Y, Yoshikawa K, Nishio K, Davies BR, Uemura H. Efficacy of targeted AKT inhibition in genetically engineered mouse models of PTEN-deficient prostate cancer. Oncotarget. 2016;7(13):15959\u201376.","journal-title":"Oncotarget"},{"issue":"17","key":"1118_CR20","doi-asserted-by":"publisher","first-page":"e122688","DOI":"10.1172\/jci.insight.122688","volume":"4","author":"MA De Velasco","year":"2019","unstructured":"De Velasco MA, Kura Y, Sakai K, Hatanaka Y, Davies BR, Campbell H, et al. Targeting castration-resistant prostate cancer with androgen receptor antisense oligonucleotide therapy. JCI Insight. 2019;4(17):e122688.","journal-title":"JCI Insight"},{"issue":"15","key":"1118_CR21","doi-asserted-by":"publisher","first-page":"3683","DOI":"10.3390\/cancers13153683","volume":"13","author":"K Sakai","year":"2021","unstructured":"Sakai K, De Velasco MA, Kura Y, Nishio K. Transcriptome profiling and metagenomic analysis help to elucidate interactions in an inflammation-associated cancer mouse model. Cancers (Basel). 2021;13(15):3683.","journal-title":"Cancers (Basel)"},{"issue":"9","key":"1118_CR22","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1111\/j.1745-7254.2007.00695.x","volume":"28","author":"ML Clapper","year":"2007","unstructured":"Clapper ML, Cooper HS, Chang WC. Dextran sulfate sodium-induced colitis-associated neoplasia: a promising model for the development of chemopreventive interventions. Acta Pharmacol Sin. 2007;28(9):1450\u20139.","journal-title":"Acta Pharmacol Sin"},{"issue":"4","key":"1118_CR23","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1002\/ijc.2910600415","volume":"60","author":"MJ Wargovich","year":"1995","unstructured":"Wargovich MJ, Chen CD, Harris C, Yang E, Velasco M. Inhibition of aberrant crypt growth by non-steroidal anti-inflammatory agents and differentiation agents in the rat colon. Int J Cancer. 1995;60(4):515\u20139.","journal-title":"Int J Cancer"},{"issue":"5","key":"1118_CR24","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1053\/j.gastro.2022.01.023","volume":"162","author":"N Krugliak Cleveland","year":"2022","unstructured":"Krugliak Cleveland N, Torres J, Rubin DT. What does disease progression look like in ulcerative colitis, and how might it be prevented? Gastroenterology. 2022;162(5):1396\u2013408.","journal-title":"Gastroenterology"},{"issue":"6","key":"1118_CR25","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1136\/mp.51.6.327","volume":"51","author":"SN Andersen","year":"1998","unstructured":"Andersen SN, Rognum TO, Bakka A, Clausen OP. Ki-67: a useful marker for the evaluation of dysplasia in ulcerative colitis. Mol Pathol. 1998;51(6):327\u201332.","journal-title":"Mol Pathol"},{"issue":"6","key":"1118_CR26","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1016\/S0002-9440(10)65517-4","volume":"155","author":"AM De Marzo","year":"1999","unstructured":"De Marzo AM, Marchi VL, Epstein JI, Nelson WG. Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis. Am J Pathol. 1999;155(6):1985\u201392.","journal-title":"Am J Pathol"},{"issue":"6","key":"1118_CR27","doi-asserted-by":"publisher","first-page":"112637","DOI":"10.1016\/j.celrep.2023.112637","volume":"42","author":"A B\u00e9nard","year":"2023","unstructured":"B\u00e9nard A, Mittelst\u00e4dt A, Kl\u00f6sch B, Glanz K, M\u00fcller J, Schoen J, et al. IL-3 orchestrates ulcerative colitis pathogenesis by controlling the development and the recruitment of splenic reservoir neutrophils. Cell Rep. 2023;42(6):112637.","journal-title":"Cell Rep"},{"issue":"1","key":"1118_CR28","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/imr.13176","volume":"314","author":"BB Antuamwine","year":"2023","unstructured":"Antuamwine BB, Bosnjakovic R, Hofmann-Vega F, Wang X, Theodosiou T, Iliopoulos I, et al. N1 versus N2 and PMN-MDSC: a critical appraisal of current concepts on tumor-associated neutrophils and new directions for human oncology. Immunol Rev. 2023;314(1):250\u201379.","journal-title":"Immunol Rev"},{"issue":"16","key":"1118_CR29","doi-asserted-by":"publisher","first-page":"8470","DOI":"10.3390\/ijms22168470","volume":"22","author":"H Wang","year":"2021","unstructured":"Wang H, Tian T, Zhang J. Tumor-associated macrophages (TAMs) in colorectal cancer (CRC): from mechanism to therapy and prognosis. Int J Mol Sci. 2021;22(16):8470.","journal-title":"Int J Mol Sci"},{"issue":"14","key":"1118_CR30","doi-asserted-by":"publisher","first-page":"1095098","DOI":"10.3389\/fimmu.2023.1095098","volume":"10","author":"C Zhang","year":"2023","unstructured":"Zhang C, Zhang J, Zhang Y, Song Z, Bian J, Yi H, et al. Identifying neutrophil-associated subtypes in ulcerative colitis and confirming neutrophils promote colitis-associated colorectal cancer. Front Immunol. 2023;10(14):1095098.","journal-title":"Front Immunol"},{"issue":"1","key":"1118_CR31","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discov. 2022;12(1):31\u201346.","journal-title":"Cancer Discov"},{"issue":"1","key":"1118_CR32","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1093\/jjco\/hyaa253","volume":"51","author":"M Hori","year":"2021","unstructured":"Hori M, Palmer M. Age-specific prostate cancer incidence rate in the world. Jpn J Clin Oncol. 2021;51(1):164\u20135.","journal-title":"Jpn J Clin Oncol"},{"issue":"4","key":"1118_CR33","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1053\/j.gastro.2018.06.043","volume":"155","author":"SC Shah","year":"2018","unstructured":"Shah SC, Khalili H, Gower-Rousseau C, Olen O, Benchimol EI, Lynge E, et al. Sex-based differences in incidence of inflammatory bowel diseases-pooled analysis of population-based studies from western countries. Gastroenterology. 2018;155(4):1079-1089.e3.","journal-title":"Gastroenterology"},{"issue":"5","key":"1118_CR34","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.2353\/ajpath.2010.080747","volume":"176","author":"M Khalili","year":"2010","unstructured":"Khalili M, Mutton LN, Gurel B, Hicks JL, De Marzo AM, Bieberich CJ. Loss of Nkx31 expression in bacterial prostatitis: a potential link between inflammation and neoplasia. Am J Pathol. 2010;176(5):2259\u201368.","journal-title":"Am J Pathol"},{"issue":"2 Pt 2","key":"1118_CR35","first-page":"S36","volume":"171","author":"EA Platz","year":"2004","unstructured":"Platz EA, De Marzo AM. Epidemiology of inflammation and prostate cancer. J Urol. 2004;171(2 Pt 2):S36-40.","journal-title":"J Urol"},{"issue":"3","key":"1118_CR36","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41391-021-00392-7","volume":"25","author":"AS Desai","year":"2022","unstructured":"Desai AS, Sagar V, Lysy B, Weiner AB, Ko OS, Driscoll C, et al. Inflammatory bowel disease induces inflammatory and pre-neoplastic changes in the prostate. Prostate Cancer Prostatic Dis. 2022;25(3):463\u201371.","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"1","key":"1118_CR37","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.jcmgh.2021.03.002","volume":"12","author":"B Drury","year":"2021","unstructured":"Drury B, Hardisty G, Gray RD, Ho GT. Neutrophil extracellular traps in inflammatory bowel disease: pathogenic mechanisms and clinical translation. Cell Mol Gastroenterol Hepatol. 2021;12(1):321\u201333.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"1","key":"1118_CR38","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1158\/1541-7786.MCR-19-0595","volume":"18","author":"JP Maynard","year":"2020","unstructured":"Maynard JP, Ertunc O, Kulac I, Baena-Del Valle JA, De Marzo AM, Sfanos KS. IL8 expression is associated with prostate cancer aggressiveness and androgen receptor loss in primary and metastatic prostate cancer. Mol Cancer Res. 2020;18(1):153\u201365.","journal-title":"Mol Cancer Res"},{"issue":"5","key":"1118_CR39","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.3390\/cancers15051375","volume":"15","author":"K Fujita","year":"2023","unstructured":"Fujita K, Matsushita M, De Velasco MA, Hatano K, Minami T, Nonomura N, Uemura H. The gut-prostate axis: a new perspective of prostate cancer biology through the gut microbiome. Cancers (Basel). 2023;15(5):1375.","journal-title":"Cancers (Basel)"},{"issue":"5","key":"1118_CR40","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.ccr.2013.10.009","volume":"24","author":"H Katoh","year":"2013","unstructured":"Katoh H, Wang D, Daikoku T, Sun H, Dey SK, Dubois RN. CXCR2-expressing myeloid-derived suppressor cells are essential to promote colitis-associated tumorigenesis. Cancer Cell. 2013;24(5):631\u201344.","journal-title":"Cancer Cell"},{"issue":"1","key":"1118_CR41","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12876-023-02693-8","volume":"23","author":"X Gao","year":"2023","unstructured":"Gao X, Duan S, Cao Y, Zhang Y. Change of monocytes\/macrophages in ulcerative colitis patients with symptoms of anxiety and depression. BMC Gastroenterol. 2023;23(1):67.","journal-title":"BMC Gastroenterol"},{"issue":"4","key":"1118_CR42","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1002\/cncr.11152","volume":"97","author":"AA Khorana","year":"2003","unstructured":"Khorana AA, Ryan CK, Cox C, Eberly S, Sahasrabudhe DM. Vascular endothelial growth factor, CD68, and epidermal growth factor receptor expression and survival in patients with Stage II and Stage III colon carcinoma: a role for the host response in prognosis. Cancer. 2003;97(4):960\u20138.","journal-title":"Cancer"},{"issue":"5","key":"1118_CR43","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1093\/ibd\/izad312","volume":"30","author":"C Yang","year":"2024","unstructured":"Yang C, Merlin D. Unveiling colitis: a journey through the dextran sodium sulfate-induced model. Inflamm Bowel Dis. 2024;30(5):844\u201353.","journal-title":"Inflamm Bowel Dis"},{"issue":"5","key":"1118_CR44","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1007\/s10620-023-07871-y","volume":"68","author":"SY Kim","year":"2023","unstructured":"Kim SY, Park JH, Leite G, Pimentel M, Rezaie A. Interleukin-10 knockout mice do not reliably exhibit macroscopic inflammation: a natural history endoscopic surveillance study. Dig Dis Sci. 2023;68(5):1858\u201362.","journal-title":"Dig Dis Sci"}],"container-title":["Human Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-024-01118-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13577-024-01118-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-024-01118-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T14:15:56Z","timestamp":1728483356000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13577-024-01118-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,20]]},"references-count":44,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["1118"],"URL":"https:\/\/doi.org\/10.1007\/s13577-024-01118-2","relation":{},"ISSN":["1749-0774"],"issn-type":[{"value":"1749-0774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,20]]},"assertion":[{"value":"10 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflict of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Institutional Review Committee at Kindai University Faculty of Medicine under protocols KDMS-18-008 and KDMS-20-035.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}